RedHill Biopharma Ltd.

NasdaqCM:RDHL Stock Report

Market Cap: US$8.7m

RedHill Biopharma Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for RedHill Biopharma.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth23.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate

Sep 10
This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate

RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks

Jul 28
RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks

One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts

Nov 24
One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts

RedHill Biopharma receives Nasdaq notification regarding minimum bid price deficiency

Oct 18

RedHill wins EU’s orphan drug status to RHB-204 for rare lung disease

Aug 17

RedHill: Given Up For Dead

Apr 30

RedHill Biopharma: Looking At An Unexciting Dead-End

Dec 30

RedHill Biopharma Ltd. (NASDAQ:RDHL) Just Reported, And Analysts Assigned A US$15.79 Price Target

Dec 02
RedHill Biopharma Ltd. (NASDAQ:RDHL) Just Reported, And Analysts Assigned A US$15.79 Price Target

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RedHill Biopharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqCM:RDHL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20244-30-24-24N/A
3/31/20244-28-32-32N/A
12/31/2023724-36-36N/A
9/30/20231934-29-29N/A
6/30/20233612-26-26N/A
3/31/202352-1-32-32N/A
12/31/202262-72-29-29N/A
9/30/202271-92-42-42N/A
6/30/202275-78-55-55N/A
3/31/202278-95-57-57N/A
12/31/202186-98-65-65N/A
9/30/202185-98-63-63N/A
6/30/202184-95-54-54N/A
3/31/202184-82-103-50N/A
12/31/202064-76-102-49N/A
9/30/202044-64-104-50N/A
6/30/202025-55-102-48N/A
3/31/20206-50-45-44N/A
12/31/20196-42-41-41N/A
9/30/20196-38-35-35N/A
6/30/20197-39-35-35N/A
3/31/20198-39-33-32N/A
12/31/20188-39-35-34N/A
9/30/20189-42-40-40N/A
6/30/20188-47-44-43N/A
3/31/20186-47N/A-44N/A
12/31/20174-46N/A-45N/A
9/30/20172-43N/A-41N/A
6/30/20171-37N/A-38N/A
3/31/20170-32N/A-34N/A
12/31/20160-29N/A-28N/A
9/30/20160-28N/A-24N/A
6/30/20160-22N/A-20N/A
3/31/20160-22N/A-19N/A
12/31/20150-21N/A-18N/A
9/30/20150-20N/A-18N/A
6/30/20150-21N/A-18N/A
3/31/20150-19N/A-17N/A
12/31/20147-11N/A-12N/A
9/30/20147-9N/A-9N/A
6/30/20147-7N/A-7N/A
3/31/20147-5N/A-5N/A
12/31/20130-11N/A-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if RDHL's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if RDHL's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if RDHL's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if RDHL's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if RDHL's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if RDHL's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y